Otsuka has dumped a clutch of clinical cancer candidates on Valentine's day. The Japanese drugmaker said “strategic reasons”—the pharma equivalent of “it’s not you, it’s me”—underpinned the decision to ax the assets.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,